These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21643632)
1. Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases. Carrafiello G; Fontana F; Cotta E; Petullà M; Brunese L; Mangini M; Fugazzola C Radiol Med; 2011 Oct; 116(7):1059-66. PubMed ID: 21643632 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230 [TBL] [Abstract][Full Text] [Related]
4. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of radiofrequency thermal ablation (RFA) of liver metastases from colorectal cancer (CRC): size as the leading prognostic factor for survival. Veltri A; Guarnieri T; Gazzera C; Busso M; Solitro F; Fora G; Racca P Radiol Med; 2012 Oct; 117(7):1139-51. PubMed ID: 22430677 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994 [TBL] [Abstract][Full Text] [Related]
7. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma. Pan C; Wu P; Yu J; Li W; Huang Z; He N; Wang J; Zhao M Int J Hyperthermia; 2011; 27(6):549-54. PubMed ID: 21846191 [TBL] [Abstract][Full Text] [Related]
8. Hepatic radiofrequency under CT-fluoroscopy guidance. Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130 [TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366 [TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Yun BL; Lee JM; Baek JH; Kim SH; Lee JY; Han JK; Choi BI Korean J Radiol; 2011; 12(5):579-87. PubMed ID: 21927559 [TBL] [Abstract][Full Text] [Related]
11. Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept. Ritz JP; Lehmann KS; Reissfelder C; Albrecht T; Frericks B; Zurbuchen U; Buhr HJ Int J Colorectal Dis; 2006 Jan; 21(1):25-32. PubMed ID: 15875202 [TBL] [Abstract][Full Text] [Related]
14. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer. Yang PC; Lin BR; Chen YC; Lin YL; Lai HS; Huang KW; Liang JT Medicine (Baltimore); 2016 Apr; 95(14):e3338. PubMed ID: 27057913 [TBL] [Abstract][Full Text] [Related]
15. Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease. Veltri A; Gazzera C; Barrera M; Busso M; Solitro F; Filippini C; Garetto I Radiol Med; 2014 May; 119(5):327-33. PubMed ID: 24297589 [TBL] [Abstract][Full Text] [Related]